Iva Milić Vranješ1,2, Ivan Školka3, Jelena Jakab4,5, Ivana Krajina1,6, Vinko Krajina1,7, Andrijana Šantić1,8, Lada Zibar1,9. 1. Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, J. Huttlera 4, 31000, Osijek, Croatia. 2. Clinic for Gynecology and Obstetrics, Osijek University Hospital, J. Huttlera 4, 31000, Osijek, Croatia. 3. Institute of Emergency Medicine of Vukovar-Srijem County, Kralja Zvonimira 53, 32100, Vinkovci, Croatia. 4. Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, J. Huttlera 4, 31000, Osijek, Croatia. jelena.jakab@fdmz.hr. 5. Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, Crkvena 21, 31000, Osijek, Croatia. jelena.jakab@fdmz.hr. 6. Department of Dermatology and Venerology, Osijek University Hospital, J. Huttlera 4, 31000, Osijek, Croatia. 7. Department of Urology, Osijek University Hospital, J. Huttlera 4, 31000, Osijek, Croatia. 8. Clinic for Psychiatry, Osijek University Hospital, J. Huttlera 4, 31000, Osijek, Croatia. 9. Department for Nephrology, Internal Clinic, University Hospital Merkur, Zajčeva 19, 10000, Zagreb, Croatia.
Abstract
PURPOSE: Difficulties in sexual functioning are very frequent in patients with chronic kidney disease (CKD). Sexual dysfunction (SD) can significantly diminish the quality of life (QOL) of affected individuals. The aim of this study was to determine the prevalence of SD in female patients undergoing chronic hemodialysis (CHD) and after renal transplantation (RTx) and to compare these groups with each other and with healthy control. METHODS: The survey was conducted among 123 female participants in a relationship, 28 of them undergoing CHD, 39 after RTx, and 56 healthy women without CKD. For the assessment of the sexual function and comorbidities, the Female Sexual Function Index (FSFI) questionnaire and Ifudu Comorbidity Index were used, respectively. RESULTS: Median age of all female participants was 60 (50-68). The median age of female CHD patients was 66 (61.3-72.8), RTx patients 56 (48-61), and the control group 59.5 (47.5-67.75). Among all participants, CHD female patients had the lowest scores in all sexual functioning domains. Compared to their age-adjusted control group, CHD patients had lower scores in desire, orgasm, and FSFI full score, whereas RTx patients had lower total FSFI scores and scores in all domains except for desire compared to their controls. Women with lower education, in marriage, and with more comorbidities had lower scores in sexual function domains. CONCLUSION: Our study shows that SD in female patients undergoing CHD treatment or those after RTx is substantially higher than that in healthy women. We suggest that female patient treated for CKD should have proper care regarding their sexual health, and differences in demographic and medical factors should be taken into consideration during the treatment management.
PURPOSE: Difficulties in sexual functioning are very frequent in patients with chronic kidney disease (CKD). Sexual dysfunction (SD) can significantly diminish the quality of life (QOL) of affected individuals. The aim of this study was to determine the prevalence of SD in female patients undergoing chronic hemodialysis (CHD) and after renal transplantation (RTx) and to compare these groups with each other and with healthy control. METHODS: The survey was conducted among 123 female participants in a relationship, 28 of them undergoing CHD, 39 after RTx, and 56 healthy women without CKD. For the assessment of the sexual function and comorbidities, the Female Sexual Function Index (FSFI) questionnaire and Ifudu Comorbidity Index were used, respectively. RESULTS: Median age of all female participants was 60 (50-68). The median age of female CHD patients was 66 (61.3-72.8), RTx patients 56 (48-61), and the control group 59.5 (47.5-67.75). Among all participants, CHD female patients had the lowest scores in all sexual functioning domains. Compared to their age-adjusted control group, CHD patients had lower scores in desire, orgasm, and FSFI full score, whereas RTx patients had lower total FSFI scores and scores in all domains except for desire compared to their controls. Women with lower education, in marriage, and with more comorbidities had lower scores in sexual function domains. CONCLUSION: Our study shows that SD in female patients undergoing CHD treatment or those after RTx is substantially higher than that in healthy women. We suggest that female patient treated for CKD should have proper care regarding their sexual health, and differences in demographic and medical factors should be taken into consideration during the treatment management.
Authors: Ronald W Lewis; Kersten S Fugl-Meyer; R Bosch; Axel R Fugl-Meyer; Edward O Laumann; E Lizza; Antonio Martin-Morales Journal: J Sex Med Date: 2004-07 Impact factor: 3.802